lilly trials retatrutide Eli and Company's triple agonist, retatrutide, successful in two additional phase 3 obesity trials, delivering significant improvements in weight and A1C New Eli Lilly Drug Retatrutide

Increased pulse wave velocity and relationship with inflammation, insulin, and insulin resistance in inflammatory bowel disease

MT: Data curation, Investigation, Methodology, Writing original draft

The effect of dietary L-carnitine on inflammatory gene expression The expressions of three inflammation-related genes were measured to investigate the potential effects of dietary L-carnitine on inflammation

GLP-1 medications already slow down your digestive system, and dehydration can make this gastric emptying process even slower, leading to worse side effects

Isorhamnetin in quinoa whole-grain flavonoids intervenes in non-alcoholic fatty liver disease by modulating bile acid metabolism through regulation of FXR expression